chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Pyuria, Sepsis, Urinary tract infection, Urine leukocyte esterase positive
Clinical narrative: Patient was exceptionally tired 10/24/2022 to 10/27/2022. The evening of 10/27/2022 she had diarrhea and emesis. She had nausea but not dysuria. Patient was brought to the ER at 5 AM on 10/28/2022. Patient was presented to the ER 10/28/2022 with fever, chills, myalgias. In the ER, she was documented pyuria. Patient was diagnosed with Sepsis secondary to UTI. UTI was confirmed with urine cultures. Workup revealed UTI with positive LE and nitrite and 25 WBCs. This event is not a continuation of a previous episode of Sepsis on 8/22/2022. Patient was treated with ceftriaxone and cipro. During this stay, patient developed polyarthritis, suspected reactive arthritis, on 11/1/2022. This caused pain in right hand and foot pain, swelling, and left neck pain. Patient had no fever at this point. A steroid burst with complete resolution in pain for the reactive arthritis. Prednisone taper was started for reactive arthritis: 20 mg daily x 5 days, followed by 15 mg daily x 5 days, followed by 10 mg daily x 5 days, then resume home dose of prednisone 5 mg daily. Evaluation of hand: severe osteoarthrosis of the STT joint. Moderate osteoarthrosis at the first CMC joint. Mild to moderate osteoarthrosis of the MCP joints. Mild osteoarthrosis of the interphalangeal joints. Small ossicle distal to the pisiform and triquetrum, well marginated and likely from old trauma. Otherwise negative. No acute or subacute fracture. No chondrocalcinosis. Subject was administered the Janssen Ad26.CoV2.S vaccine on 10/17/2022. This adverse event is unrelated to the Janssen Ad26.CoV2.S vaccine that was administered on 10/17/2022. Patient was discharged from the hospital on 11/4/2022 in stable condition. Sepsis resolving/resolved with follow-up requested. Swelling resolving. Follow-up appointments were scheduled.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting, White blood cell count increased, White blood cells urine positive
Clinical narrative: Patient was exceptionally tired 10/24/2022 to 10/27/2022. The evening of 10/27/2022 she had diarrhea and emesis. She had nausea but not dysuria. Patient was brought to the ER at 5 AM on 10/28/2022. Patient was presented to the ER 10/28/2022 with fever, chills, myalgias. In the ER, she was documented pyuria. Patient was diagnosed with Sepsis secondary to UTI. UTI was confirmed with urine cultures. Workup revealed UTI with positive LE and nitrite and 25 WBCs. This event is not a continuation of a previous episode of Sepsis on 8/22/2022. Patient was treated with ceftriaxone and cipro. During this stay, patient developed polyarthritis, suspected reactive arthritis, on 11/1/2022. This caused pain in right hand and foot pain, swelling, and left neck pain. Patient had no fever at this point. A steroid burst with complete resolution in pain for the reactive arthritis. Prednisone taper was started for reactive arthritis: 20 mg daily x 5 days, followed by 15 mg daily x 5 days, followed by 10 mg daily x 5 days, then resume home dose of prednisone 5 mg daily. Evaluation of hand: severe osteoarthrosis of the STT joint. Moderate osteoarthrosis at the first CMC joint. Mild to moderate osteoarthrosis of the MCP joints. Mild osteoarthrosis of the interphalangeal joints. Small ossicle distal to the pisiform and triquetrum, well marginated and likely from old trauma. Otherwise negative. No acute or subacute fracture. No chondrocalcinosis. Subject was administered the Janssen Ad26.CoV2.S vaccine on 10/17/2022. This adverse event is unrelated to the Janssen Ad26.CoV2.S vaccine that was administered on 10/17/2022. Patient was discharged from the hospital on 11/4/2022 in stable condition. Sepsis resolving/resolved with follow-up requested. Swelling resolving. Follow-up appointments were scheduled.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Arthralgia
Clinical narrative: Severe joint pain from pfizer bivalent 4th booster. Required steroid pack and then steroid injection along with flexibility. Lasting week and half so far. Also had reaction with 1st booster similar but not as bad.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Angiogram cerebral abnormal, Anisocoria, Arterial flow velocity decreased, Blood calcium decreased, Blood creatinine normal
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood magnesium, Blood potassium normal, Blood sodium decreased, Carotid artery occlusion
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Carotid artery thrombosis, Cerebellar infarction, Cerebral artery occlusion, Cerebral infarction, Cerebrovascular accident
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Communication disorder, Computerised tomogram head normal, Condition aggravated, Depressed level of consciousness, Eye movement disorder
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Facial paralysis, Glomerular filtration rate normal, Hemiparesis, Hypertension, Hypothyroidism
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotonia, Imaging procedure, Ischaemic stroke, Magnetic resonance imaging head abnormal, Neurogenic bladder
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Neurological decompensation, Pupillary disorder, Sepsis, Speech disorder, Tachycardia
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Tachypnoea, Unresponsive to stimuli, Upper motor neurone lesion, White blood cell count increased
Clinical narrative: Patient was admitted to the hospital on 11/20/2022 in the morning. She admitted for right-sided weakness and impaired speech. Upon awakening the morning of 11/20/2022, patient's spouse noticed the change in her neurological status and called EMS. At the hospital she was diagnosed with Acute ischemic stroke and Sepsis-- patient meets sepsis criteria for tachycardia, tachypnea, and elevated WBC count. Left MCA + right cerebellar. CT negative for hemorrhage. CTA revealed L ICA occlusion with partial thrombosis of terminal segment and occlusion of L M3. TNK not administered; patient out of the treatment window. Thrombectomy not performed; imaging negative for large vessel occlusion. HEAD CT: No intracranial hemorrhage, mass, or definite CT evidence of recent ischemia. HEAD CTA: The left internal carotid artery is occluded proximally through most of its intracranial course with partial thrombosis of the terminal segment, there is occlusion of a distal M2 branch of the left middle cerebral artery. MR HEAD BRAIN WO CONTRAST (11/20/2022): Hyperacute left middle cerebral artery territory infarcts, acute/early subacute superior right cerebellar infarcts, diminished or absent flow within the left internal carotid artery and left middle cerebral artery branches as identified on CTA. Neuro assessment limited due to decreased level of consciousness. Right-sided facial droop present. Left-sided gaze preference. She was not attentive to right-sided stimuli, nor was she able to cross midline with her pupils. Right sided pupil slightly larger than the left. Unable to assess visual acuity. RUE flaccid and not reactive to painful stimuli. LUE positive for drift. RLE withdrawals from pain. LLE negative for drift; full strength. Patient made no attempt to communicate. She was able to follow some commands. Patient received the Janssen Ad26.CoV2.S Vaccine on 10/17/2022 for research study. Per study PI, this event is unrelated to the Janssen Ad.26.CoV2.S Vaccine that was administered on 10/17/2022.
Sex: U
Vaccine: COVID19, FLUX
Symptoms: Back pain, Eczema, Muscular weakness, Seizure, Sensory disturbance
Clinical narrative: PT reported skin feeling like it had "bee stings," eczema, weak muscles (PT described muscles would "sink"), body convulsion, and lower back pain. PT did consent to follow up.
Sex: M
Vaccine: FLUR4
Symptoms: Death
Clinical narrative: Father received FluBlok quadrivalent flu vaccine made by Protein Sciences Corporation. Died 2 days later. only prescribed medication was Amlodipine Besylate 10mg tab, precribed 11/15/2022. 1 tablet by mouth daily
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received Pfizer monovalent vaccine instead of bivalent vaccine
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Patient received monovalent Pfizer vaccine instead of bivalent Pfizer vaccine
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Angiogram, Balance disorder, Balance test, Electrocardiogram
Clinical narrative: I've had 5 Civid 19 vaccines. I am having brain fog, imbalance and vertigo like symptoms, worsening an constant. Heart palpitations. I've need to 3 ENT's, 2 neurosurgeons, 2 neurologists, 1 cardiologist, 1 pulmonologist, 1 orthopedic dr. I've had Brain and neck MRI/MRA's, CT Angiograms, balance tests, hearing tests, EEG's EKG's. Nothing. The symptoms worsen and all the Drs asked if I've had Covid. I have not but I've had 5 Covid inoculations. I'm 72. I need some answers. I have friends at tge agency. I will pursue this. Please call me. I have my accident card 1st shot in Feb 2021 last one May 2022. 5 in Total
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Electroencephalogram, Feeling abnormal, Magnetic resonance imaging head, Magnetic resonance imaging neck, Palpitations
Clinical narrative: I've had 5 Civid 19 vaccines. I am having brain fog, imbalance and vertigo like symptoms, worsening an constant. Heart palpitations. I've need to 3 ENT's, 2 neurosurgeons, 2 neurologists, 1 cardiologist, 1 pulmonologist, 1 orthopedic dr. I've had Brain and neck MRI/MRA's, CT Angiograms, balance tests, hearing tests, EEG's EKG's. Nothing. The symptoms worsen and all the Drs asked if I've had Covid. I have not but I've had 5 Covid inoculations. I'm 72. I need some answers. I have friends at tge agency. I will pursue this. Please call me. I have my accident card 1st shot in Feb 2021 last one May 2022. 5 in Total
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vertigo
Clinical narrative: I've had 5 Civid 19 vaccines. I am having brain fog, imbalance and vertigo like symptoms, worsening an constant. Heart palpitations. I've need to 3 ENT's, 2 neurosurgeons, 2 neurologists, 1 cardiologist, 1 pulmonologist, 1 orthopedic dr. I've had Brain and neck MRI/MRA's, CT Angiograms, balance tests, hearing tests, EEG's EKG's. Nothing. The symptoms worsen and all the Drs asked if I've had Covid. I have not but I've had 5 Covid inoculations. I'm 72. I need some answers. I have friends at tge agency. I will pursue this. Please call me. I have my accident card 1st shot in Feb 2021 last one May 2022. 5 in Total
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Angiogram, Dizziness, Electroencephalogram, Electromyogram, Magnetic resonance imaging
Clinical narrative: I've had 5 Civid 19 vaccines. I am having brain fog, imbalance and vertigo like symptoms, worsening an constant. Heart palpitations. I've need to 3 ENT's, 2 neurosurgeons, 2 neurologists, 1 cardiologist, 1 pulmonologist, 1 orthopedic dr. I've had Brain and neck MRI/MRA's, CT Angiograms, balance tests, hearing tests, EEG's EKG's. Nothing. The symptoms worsen and all the Drs asked if I've had Covid. I have not but I've had 5 Covid inoculations. I'm 72. I need some answers. I have friends at tge agency. I will pursue this. Please call me. I have my accident card 1st shot in Feb 2021 last one May 2022. 5 in Total
Age: 72.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: I've had 5 Civid 19 vaccines. I am having brain fog, imbalance and vertigo like symptoms, worsening an constant. Heart palpitations. I've need to 3 ENT's, 2 neurosurgeons, 2 neurologists, 1 cardiologist, 1 pulmonologist, 1 orthopedic dr. I've had Brain and neck MRI/MRA's, CT Angiograms, balance tests, hearing tests, EEG's EKG's. Nothing. The symptoms worsen and all the Drs asked if I've had Covid. I have not but I've had 5 Covid inoculations. I'm 72. I need some answers. I have friends at tge agency. I will pursue this. Please call me. I have my accident card 1st shot in Feb 2021 last one May 2022. 5 in Total
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Headache, Oropharyngeal pain, Pain in extremity, Throat irritation
Clinical narrative: vaccine.  later that day headache and sore arm.  2am next day throat itchy and painful, later extreme headache and chest pain.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: COVID vaccine breakthrough case.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test, Full blood count, Hypoaesthesia, Metabolic function test, Pain
Clinical narrative: Pt started havng left arm pain. Describes as aching and sore, throbbing, initially pain was all the way down, now from her elbow down to hand, Reports pin and needle feeling on her left arm, numbness and tingling.  She is right handed.
Age: 63.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain in extremity, Paraesthesia, Vitamin B12, Vitamin D
Clinical narrative: Pt started havng left arm pain. Describes as aching and sore, throbbing, initially pain was all the way down, now from her elbow down to hand, Reports pin and needle feeling on her left arm, numbness and tingling.  She is right handed.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Abdominal pain, Mobility decreased, Muscle tightness, Pyrexia, Screaming
Clinical narrative: . Fever 102, muscles were so tight that she could barely move or bend arms or raise arms, screaming in abdominal pain (stabbing sensation). Fever seems to have passed, but she is still unable to lift arms and abdominal pain is still pretty severe. Mom has NEVER seen this type of reaction.
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against then tested positive for COVID 19
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event, Product storage error
Clinical narrative: There was a vaccine clinic run by an RN the morning of administration. There were 6 covid vaccines drawn 10/17/22 that were left in the fridge that evening as none had been used and they had not been wasted. The morning of 10/18/22 there was the assumption that the vaccines had been drawn by the RN for the non-clinic use. 4 coworkers, including myself, failed to check the tags on the vaccine or the sheet for administration and gave 4 pts the vaccines from 10/17. No adverse symptoms reported by any pts.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT WAS GIVEN PFIZER VACCINE FROM PREVIOUS DAY. STAFF MEMEBER DID NOT PAY ATTENTION TO DATE AND TIME IT WAS OPENED.
Age: 51.0
Sex: F
Vaccine: FLU4
Symptoms: Incorrect route of product administration, Injection site infection, Magnetic resonance imaging, Shoulder injury related to vaccine administration, Ultrasound scan
Clinical narrative: The injection was given incorrect and placed in my shoulder! I have SIRVA  Infection in my shoulder.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Headache, Malaise, No adverse event, Pain
Clinical narrative: I had no reaction to the vaccine. On 07/21/2022, I started not feeling well with body aches and a headache. On  07/23/2022, I tested positive with a home test for COVID-19. I contacted my doctor on 07/25/2022 and was given a prescription for PAXLOVID.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had no reaction to the vaccine. On 07/21/2022, I started not feeling well with body aches and a headache. On  07/23/2022, I tested positive with a home test for COVID-19. I contacted my doctor on 07/25/2022 and was given a prescription for PAXLOVID.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pfizer monovalent vaccine was given to patient instead of ordered Pfizer bivalent vaccine.  Patient contacted and notified of error, advised they should receive bivalent booster 2 months after the incorrect monovalent dose.  PCP notified of error.  No signs or symptoms of adverse reaction reported by patient.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Hyperhidrosis, Respiratory distress
Clinical narrative: On November 22, 2022, Patient received the Moderna Bivalent booster at the Mass Vaccination event. The patient received vaccine at 10:15, Moderna Bivalent lot # 016H22A, in her left Deltoid. At 10:28 she started to fill dizzy/lightheaded, nursing staff had her sit down and started to triage. She presented A&Ox3, bilaterally lung sounds clear, BP 145/93, pulse 72, diaphoretic, no s/s of respiratory distress, O2 was given by nasal cannula at 2 liters. Reassessed at 10:30 BP 139/79, pulse 70, A&Ox3, bilaterally lung sounds clear, diaphoretic, patient laid down on liter. At 10:38 BP 128/70, pulse 68, dry, A&Ox3. At 10:42, O2 discontinued, and patient moved from lying down to sitting in chair BP 125/74, pulse 68, patient stated she was feeling less dizzy and wanted to stand up. At 10:43 patient stood up with assistance, reassessed by nurse, patient stated she was ready to go to her car. Nurse and medic walked patient to the car, where spouse was waiting for her. Nurse provided local emergency room contact information and recommended patient follow up with PCP. Patient and spouse verbalized understanding.
Age: 40.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: PATIENT RECEIVED BIVALENT INSTEAD OF FIRST DOSE OF PRIMARY SERIES
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event
Clinical narrative: Pfizer monovalent vaccine was given to patient instead of ordered Pfizer bivalent vaccine.  Patient contacted and notified of error, advised they should receive bivalent booster 2 months after the incorrect monovalent dose.  PCP notified of error.  No signs or symptoms of adverse reaction reported by patient.
Age: 25.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect product formulation administered
Clinical narrative: SHE RECEIVED BIVALENT INSTEAD OF DOSE 1 OF PRIMARY SERIES. REPORTING FOR FLOATER PHARMACIST WHO ADMINISTED VACCINE ON 10-31-22 AT MY PRIMARY PHARMACY LOCATION
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, COVID-19, Cough, Dyspnoea, Fatigue
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fear, Oxygen saturation decreased, Post-tussive vomiting, Sepsis, Tachycardia
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Vomiting
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Aphasia, Atelectasis, Bladder catheterisation, COVID-19
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Chest discomfort, Convalescent plasma transfusion, Diarrhoea
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Dyspnoea, Echocardiogram abnormal, Ejection fraction, Electrocardiogram, General physical health deterioration
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypotension, Immunodeficiency, Laboratory test, Lung infiltration, Lung opacity
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Magnetic resonance imaging head normal, Pneumonia, Prohormone brain natriuretic peptide, Pyrexia, Right ventricular dilatation
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Systolic dysfunction, Tachycardia, Tachypnoea
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Troponin
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.
Age: 89.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Acute respiratory failure, Aphasia, Asthma, Atrial fibrillation, Bladder catheterisation
Clinical narrative: PRESENTING PROBLEM: Acute respiratory insufficiency COVID-19 Sepsis due to COVID-19   HOSPITAL COURSE: Patient is a 91 y.o. male who presented with symptoms of cough, shortness of breath and vomiting overnight. His wife urged him to come in. He repeatedly says he is fine and not sick. He eventually admits that he was having difficulty catching his breath when he was outside hunting. This has been going on for about a week. His wife also says that he has been complaining of fatigue over the past week as well. He denies diarrhea, fevers, sweats or chills. He was using his albuterol more than usual during the last day but was not using his spacer. He usually doesn't need to use his albuterol at all and only uses Dulera regularly. His shortness of breath worsened at night that led to post-tussive emesis. He started feeling much better after having duo-nebs at the hospital. He still desatted to 89% when ambulating which is not normal for him. He was also slightly tachycardic in the ER, but he did not take his metoprolol this morning in fear he would throw it up. He was discharge the next morning as he remained in improved condition without shortness of breath after being shown to use his spacer with his albuterol inhaler.